ICDD

ABOUT THE CONFERENCE 

MISSION STATEMENT: 
To offer the most informative and up to date conference in the science and regulation of global drug development

CONFERENCE THEME: Fostering Innovation and Translational Research in Support of Public Health and Economic Growth

CONFERENCE SUBTHEME:
Moving the FDA into the XXI Century – Advancing Regulatory Science into Medicines- Balancing Pharmaceutical Innovation, Drug Safety and Economic Growth

SUBTHEMES:

TARGET AUDIENCE
 Leaders in Academia, the Pharmaceutical and Biotechnology Industry (PhRMA, BIO, GPhA), Contract Research Organizations, API Manufacturers, and Domestic and international Regulatory Agencies  in positions to affect the science and regulation of drug discovery and development.

AGENDA & LEARNING OBJECTIVES

Agenda & Learning Objectives will be posted in November when Registration Opens

LOCATION/LODGING

Barton Creek Resort & Spa
8212 Barton Club Drive
Austin, TX 78735
Phone:  512.329.4000
Fax:  512.329.4597
http://www.bartoncreek.com/

REGISTRATION

Registration opens in November.  Please email us if you wish to receive the notification email when registration opens.


ACPE The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



(Download PDF Reader.)

Last Reviewed: October 19, 2011

Contact Information

Mailing Address:
The University of Texas
at Austin
College of Pharmacy
Continuing Educaton
1 University Station,
A1904
Austin, TX
78712-0123
USA

Email Address: UTPharmacyCE
@austin.utexas.edu

Phone:
1-512-471-6213
Fax:
1-512-475-9739


Past participant comments:
"Always advances my understanding in a topic area. A conference I don't like to miss."
Janet Woodock, M.D.
Director, Center for Drug Evaluation & Research, FDA
Food and Drug Administration

"What distinguishes this meeting from others I attend is the designed opportunity to interact with my peers in the industry and the FDA is an informal setting."
Gerald Yakatan, Ph.D.
Founder & Chairman
IriSys, Inc.

"This meeting is a great opportunity for industry and agency leadership to address impediments to drug development."
Keith O. Webber, Ph.D.
Deputy Director, Office of Pharmaceutical Science
Center for Drug Evaluation & Research, FDA

index of the major headings: a b c d e f g h i j k l m n o p q r s t u v w x y z